Cabaletta Bio IncNASDAQ:CABA
- LAST PRICE7.1900
- TODAY'S CHANGE (%)0.4400 (6.5185%)
- Bid / Lots7.0300/ 1
- Ask / Lots7.2400/ 5
- Open / Previous Close6.9100 / 6.7500
- Day Range
- 52 Week Range
- Volume591,227
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CABA |
|---|---|---|
| 09:32 ET | 5575 | 6.91 |
| 09:34 ET | 900 | 6.9253 |
| 09:36 ET | 200 | 6.9465 |
| 09:38 ET | 2440 | 7 |
| 09:39 ET | 930 | 6.97 |
| 09:41 ET | 1205 | 6.96 |
| 09:43 ET | 400 | 6.95 |
| 09:45 ET | 1650 | 6.98 |
| 09:48 ET | 868 | 7 |
| 09:50 ET | 2096 | 7 |
| 09:52 ET | 1100 | 7.01 |
| 09:54 ET | 1974 | 6.935 |
| 09:56 ET | 1096 | 6.98 |
| 09:57 ET | 2752 | 6.962 |
| 09:59 ET | 111 | 6.961 |
| 10:01 ET | 569 | 6.96 |
| 10:03 ET | 800 | 6.98 |
| 10:06 ET | 472 | 6.975 |
| 10:08 ET | 1800 | 6.96 |
| 10:10 ET | 300 | 6.945 |
| 10:12 ET | 100 | 6.94 |
| 10:14 ET | 1006 | 6.93 |
| 10:15 ET | 1449 | 6.94 |
| 10:17 ET | 1463 | 6.95 |
| 10:19 ET | 567 | 6.93 |
| 10:21 ET | 400 | 6.92 |
| 10:24 ET | 600 | 6.91 |
| 10:26 ET | 352 | 6.92 |
| 10:28 ET | 300 | 6.92 |
| 10:30 ET | 912 | 6.91 |
| 10:32 ET | 1224 | 6.88 |
| 10:33 ET | 1966 | 6.86 |
| 10:35 ET | 1713 | 6.86 |
| 10:37 ET | 400 | 6.855 |
| 10:39 ET | 1000 | 6.93 |
| 10:42 ET | 700 | 6.93 |
| 10:44 ET | 200 | 6.94 |
| 10:46 ET | 1940 | 6.92 |
| 10:48 ET | 200 | 6.94 |
| 10:50 ET | 400 | 6.92 |
| 10:51 ET | 200 | 6.9 |
| 10:57 ET | 905 | 6.91 |
| 11:00 ET | 755 | 6.92 |
| 11:02 ET | 18643 | 6.9 |
| 11:04 ET | 1057 | 6.93 |
| 11:06 ET | 200 | 6.93 |
| 11:08 ET | 1321 | 6.93 |
| 11:09 ET | 1179 | 6.95 |
| 11:11 ET | 831 | 6.93 |
| 11:13 ET | 100 | 6.935 |
| 11:15 ET | 981 | 6.915 |
| 11:18 ET | 100 | 6.9 |
| 11:22 ET | 200 | 6.91 |
| 11:24 ET | 400 | 6.97 |
| 11:26 ET | 474 | 6.96 |
| 11:27 ET | 100 | 6.975 |
| 11:29 ET | 500 | 6.99 |
| 11:31 ET | 918 | 6.99 |
| 11:33 ET | 1512 | 6.9602 |
| 11:36 ET | 1600 | 6.955 |
| 11:38 ET | 500 | 7 |
| 11:40 ET | 13704 | 7.095 |
| 11:42 ET | 500 | 7.125 |
| 11:44 ET | 22325 | 7.045 |
| 11:45 ET | 200 | 7.06 |
| 11:47 ET | 313 | 7.05 |
| 11:49 ET | 100 | 7.05 |
| 11:51 ET | 746 | 7.08 |
| 11:54 ET | 2855 | 7.055 |
| 11:56 ET | 888 | 7.04 |
| 11:58 ET | 300 | 7.0306 |
| 12:00 ET | 950 | 7.04 |
| 12:02 ET | 200 | 7.06 |
| 12:03 ET | 1350 | 7.07 |
| 12:05 ET | 200 | 7.08 |
| 12:07 ET | 765 | 7.13 |
| 12:09 ET | 2872 | 7.135 |
| 12:12 ET | 2738 | 7.16 |
| 12:14 ET | 3052 | 7.13 |
| 12:16 ET | 6854 | 7.1 |
| 12:18 ET | 800 | 7.1 |
| 12:20 ET | 500 | 7.095 |
| 12:21 ET | 200 | 7.08 |
| 12:23 ET | 300 | 7.08 |
| 12:25 ET | 670 | 7.095 |
| 12:27 ET | 100 | 7.095 |
| 12:30 ET | 300 | 7.11 |
| 12:32 ET | 1000 | 7.08 |
| 12:34 ET | 100 | 7.07 |
| 12:36 ET | 1012 | 7.045 |
| 12:38 ET | 500 | 7.02 |
| 12:39 ET | 155 | 7.02 |
| 12:41 ET | 100 | 7.0325 |
| 12:43 ET | 500 | 7.04 |
| 12:45 ET | 1374 | 7.035 |
| 12:48 ET | 200 | 7.035 |
| 12:50 ET | 700 | 7.01 |
| 12:52 ET | 100 | 7.01 |
| 12:54 ET | 100 | 7.01 |
| 12:56 ET | 800 | 7.02 |
| 12:57 ET | 860 | 7.0199 |
| 12:59 ET | 1527 | 7 |
| 01:01 ET | 2161 | 7.01 |
| 01:03 ET | 300 | 7 |
| 01:06 ET | 2000 | 7.03 |
| 01:08 ET | 871 | 7.02 |
| 01:10 ET | 300 | 7.02 |
| 01:14 ET | 1700 | 7.04 |
| 01:15 ET | 692 | 7.01 |
| 01:17 ET | 300 | 7.03 |
| 01:21 ET | 708 | 7.035 |
| 01:24 ET | 200 | 7.04 |
| 01:26 ET | 410 | 7.055 |
| 01:28 ET | 1928 | 7.04 |
| 01:32 ET | 100 | 7.06 |
| 01:33 ET | 400 | 7.06 |
| 01:35 ET | 1551 | 7.02 |
| 01:37 ET | 350 | 6.99 |
| 01:39 ET | 400 | 7 |
| 01:42 ET | 1045 | 7.04 |
| 01:44 ET | 200 | 7.06 |
| 01:46 ET | 1138 | 7.09 |
| 01:48 ET | 712 | 7.12 |
| 01:50 ET | 2142 | 7.08 |
| 01:51 ET | 1446 | 7.11 |
| 01:53 ET | 327 | 7.1 |
| 01:55 ET | 600 | 7.1 |
| 02:00 ET | 1937 | 7.1 |
| 02:04 ET | 2616 | 7.1 |
| 02:06 ET | 2411 | 7.09 |
| 02:08 ET | 200 | 7.09 |
| 02:11 ET | 2674 | 7.106 |
| 02:13 ET | 100 | 7.105 |
| 02:15 ET | 1265 | 7.1 |
| 02:18 ET | 24181 | 7.165 |
| 02:20 ET | 250 | 7.15 |
| 02:22 ET | 350 | 7.1629 |
| 02:24 ET | 400 | 7.17 |
| 02:26 ET | 2374 | 7.18 |
| 02:27 ET | 1245 | 7.17 |
| 02:29 ET | 3431 | 7.15 |
| 02:33 ET | 2349 | 7.15 |
| 02:36 ET | 800 | 7.15 |
| 02:38 ET | 505 | 7.17 |
| 02:40 ET | 200 | 7.155 |
| 02:42 ET | 2447 | 7.14 |
| 02:44 ET | 4299 | 7.1 |
| 02:45 ET | 716 | 7.11 |
| 02:47 ET | 423 | 7.09 |
| 02:49 ET | 600 | 7.09 |
| 02:51 ET | 1345 | 7.11 |
| 02:54 ET | 851 | 7.12 |
| 02:56 ET | 534 | 7.09 |
| 02:58 ET | 950 | 7.1 |
| 03:00 ET | 868 | 7.08 |
| 03:02 ET | 100 | 7.08 |
| 03:03 ET | 5033 | 7.05 |
| 03:05 ET | 600 | 7.06 |
| 03:07 ET | 100 | 7.04 |
| 03:09 ET | 300 | 7.07 |
| 03:12 ET | 1344 | 7.09 |
| 03:14 ET | 2446 | 7.09 |
| 03:16 ET | 937 | 7.08 |
| 03:18 ET | 14075 | 7.065 |
| 03:20 ET | 1900 | 7.1 |
| 03:21 ET | 9263 | 7.05 |
| 03:23 ET | 1995 | 7.05 |
| 03:25 ET | 4469 | 7.09 |
| 03:27 ET | 700 | 7.11 |
| 03:30 ET | 1599 | 7.09 |
| 03:34 ET | 1109 | 7.08 |
| 03:36 ET | 1150 | 7.09 |
| 03:39 ET | 2100 | 7.09 |
| 03:41 ET | 1644 | 7.11 |
| 03:43 ET | 844 | 7.1091 |
| 03:45 ET | 6687 | 7.13 |
| 03:48 ET | 300 | 7.13 |
| 03:50 ET | 4780 | 7.15 |
| 03:52 ET | 2142 | 7.17 |
| 03:54 ET | 3287 | 7.17 |
| 03:56 ET | 6690 | 7.16 |
| 03:57 ET | 5622 | 7.18 |
| 03:59 ET | 16306 | 7.19 |
Jul 2, 2024
Cabaletta Bio to Participate in the Stifel 2024 Virtual Cell Therapy Forum, from 8:00AM ET on Tuesday Jul 02, 2024 by Dow Jones
8:00AM ET on Tuesday Jul 02, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Cabaletta Bio Inc | 325.9M | -4.2x | --- |
Atea Pharmaceuticals Inc | 328.5M | -2.0x | --- |
Opthea Ltd | 328.1M | -0.9x | --- |
Prelude Therapeutics Inc | 329.0M | -3.1x | --- |
ALX Oncology Holdings Inc | 317.8M | -1.6x | --- |
Tenaya Therapeutics Inc | 313.3M | -2.4x | --- |
Company Information
Cabaletta Bio, Inc. is a clinical-stage biotechnology company. The Company is focused on the discovery and development of engineered T cell therapies that have the potential to provide deep and durable, perhaps curative, responses with one-time administration for patients with autoimmune diseases. Its Cabaletta Approach to B cell Ablation (CABA) platform encompasses two strategies: Chimeric Antigen Receptor T cells for Autoimmunity (CARTA) and Chimeric AutoAntibody Receptor T cells (CAART). CABA-201, its lead product candidate from its CARTA platform, is a 4-1BB co-stimulatory domain-containing fully human CD19-CAR T construct designed to treat patients with a range of autoimmune diseases. Its DSG3-CAART product candidate is being evaluated for the treatment of mPV, a subtype of PV that affects the epithelium of the mucous membranes, in the Phase 1 DesCAARTes TM trial. Its MuSK-CAART product candidate is designed to treat a subset of patients with MG, targeting autoreactive B cells.
Contact Information
- Headquarters
- 2929 Arch Street, Suite 600PHILADELPHIA, PA, United States 19104
- Phone
- 267-759-3100
- Fax
- 302-655-5049
Executives
- Chairman of the Board, President, Chief Executive Officer, Co-Founder
- Steven Nichtberger
- Chief Financial Officer
- Anup Marda
- President - Science and Technology
- Gwendolyn Binder-Scholl
- General Counsel, Secretary
- Michael Gerard
- Chief Medical Officer
- David Chang
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $325.9M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 48.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.43 |
EPS | $-1.73 |
Book Value | $4.94 |
P/E Ratio | -4.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
